Primary B-cell non-Hodgkin lymphoma of the parotid gland: An analysis based on the SEER database

Medicine (Baltimore). 2023 Apr 25;102(17):e33098. doi: 10.1097/MD.0000000000033098.

Abstract

Primary malignant lymphoma of the parotid gland is a rare entity. The disease is often misdiagnosed, and its survival factors remain unclear. This study included patients diagnosed with primary B-cell non-Hodgkin lymphoma of the parotid gland from 1987 to 2016 in the surveillance, epidemiology, and end results program. Univariate survival analysis was conducted using the Kaplan-Meier method, and multivariate analysis was performed using the Cox proportional hazards regression model. A competing risks regression model was applied to estimate the specific risks associated with parotid lymphoma mortality. A total of 1443 patients were identified. The overall survival of indolent primary B-cell lymphoma of the parotid gland was higher than that of aggressive lymphoma (hazard ratio 0.53, 95% confidence interval 0.44-0.64, P < .001), and older patients (≥70 years) exhibited inferior overall survival. Histological subtype and age are important prognostic factors in patients with primary B-cell non-Hodgkin lymphoma of the parotid gland.

MeSH terms

  • Humans
  • Lymphoma* / epidemiology
  • Lymphoma, B-Cell* / epidemiology
  • Parotid Gland
  • Parotid Neoplasms* / epidemiology
  • Prognosis
  • SEER Program